glp-1 prescriptions growth q1 2025 GLP-1s in 2025: Who's Using Them, Who's Covering Them, and What's Next GLP-1 Market Trends and Global

Diarrhea: Gastrointestinal discomfort, including diarrhea, may appearparticularly with higher doses or rapid dose increases

Daily rhythms of feeding in the genetically obese and lean zucker rats

When GLP-1s normal daily pattern is disturbed, it may impair glucose regulation and increase the risk of metabolic conditions

Although the liver and the skeletal muscle do not express GIPR or GLP-1R 40,45 , and are thus not directly targeted by GLP-1GIPLani, hepatic and skeletal muscle effects are nonetheless expected, given that the molecule decreases body weight and fat mass and improve glucose metabolism, which indirectly also improve metabolism in liver and skeletal muscle

October 1, 2021

How PlexusDx Supports a More Personalized Approach PlexusDx Precision Peptide Genetic Test may help provide context on your individual metabolic pathways relevant to GLP-1 response